News18 » Videos » News18 Shorts

Indian Drug Makers, Hetero And Cipla, Set To Manufacture Gilead Science’s Remdesivir

Jun 22, 2020 07:58 PM IST India India
Share

Both the companies are allowed to manufacture and supply remdesivir for ‘restricted emergency use’ on hospitalised COVID-19 patients. As per India’s clinical management guidelines, the drug will be administered in the form of an injection. But written consent is required before injecting the drug.

Loading